Results 121 to 130 of about 48,914 (162)

Anthracyclines.

Cancer chemotherapy and biological response modifiers, 1990
After twenty years, understanding the mechanisms of tumor cells kill by anthracyclines still remains an active area of research. Of many mechanisms described for this class of drugs, efforts in the last year have focused on defining the role of free radical formation, topoisomerase II-induced DNA breakage, and P-170-dependent cellular accumulation of ...
B K, Sinha, P M, Politi
openaire   +1 more source

Anthracyclines

2005
David, Hamilton, Gerald, Batist
openaire   +2 more sources

Novel Anthracycline Utorubicin for Cancer Therapy

Angewandte Chemie - International Edition, 2021
Tambet Teesalu, Lorena Simon Gracia, Valeria Sidorenko   +2 more
exaly  

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

Lancet, The, 2023
Christian Fesl, Ramya Rámaswámí, Timothy Whelan   +2 more
exaly  

Cardiotoxicity and anthracyclines

Breast Cancer Research and Treatment, 2008
Justin, Stebbing, Alison, Jones, Peter, Barrett-Lee   +2 more
openaire   +2 more sources

Cardiotoxicity of anthracyclines

European Journal of Cancer and Clinical Oncology, 1984
M D, Green, J L, Speyer, F M, Muggia
openaire   +2 more sources

Anthracyclines

1995
openaire   +2 more sources

Anthracyclines and Cardiotoxicity

Clinical Oncology, 2000
openaire   +2 more sources

Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane®) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy

Annals of Oncology, 2006
Vladimira Stahalova, Bernardo Rapoport, Marc Espié   +2 more
exaly  

cTnT can be a useful marker for early detection of anthracycline cardiotoxicity

Annals of Oncology, 2005
Ismail Çelik, Sercan Aksoy, G Tekuzman   +2 more
exaly